SLGL
SLGL
NASDAQ · Pharmaceuticals

Sol-Gel Technologies Ltd

$87.82
+21.62 (+32.66%)
As of Mar 24, 4:10 PM ET ·
Financial Highlights (FY 2026)
Revenue
11.93M
Net Income
-10,940,309
Gross Margin
Profit Margin
-91.7%
Rev Growth
-28.3%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 29.4% 29.4%
Operating Margin -104.1% -93.7% 42.3% 41.5%
Profit Margin -91.7% -87.1% 33.8% 28.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 11.93M 16.64M 80.43M 74.82M
Gross Profit 23.62M 21.97M
Operating Income -12,423,702 -15,590,256 34.02M 31.02M
Net Income -10,940,309 -13,728,775 27.17M 21.09M
Gross Margin 29.4% 29.4%
Operating Margin -104.1% -93.7% 42.3% 41.5%
Profit Margin -91.7% -87.1% 33.8% 28.2%
Rev Growth -28.3% -28.3% -4.6% -5.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 45.73M 50.34M
Total Equity 128.24M 118.27M
D/E Ratio 0.36 0.43
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -12,182,145 -16,136,416 38.14M 36.98M
Free Cash Flow 15.33M 13.15M